OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
JAYO52

Jaysynth Orgochem Ltd

Specialty ChemicalsVerified

Jaysynth Orgochem Ltd maintains a relatively strong liquidity position, with a current ratio of 4.91, indicating that the company has nearly five times more current assets than current liabilities. However, the company's net cash position is negative after subtracting total debt, which suggests that its cash and equivalents (INR 196.02 million) are insufficient to cover its long-term debt (INR 491.29 million). This highlights a potential liquidity risk, despite the high current ratio. In terms of profitability, the company's return on equity (ROE) of 11.15% and return on assets (ROA) of 6.27% are both below the typical thresholds for high-performing specialty chemical firms. These metrics suggest that the company is generating returns, but not at a level that would be considered exceptional within the industry. The operating margin, calculated as operating income (INR 155.71 million) divided by revenue (INR 2.11 billion), is approximately 7.37%, which is in line with the industry median for similar-sized firms. The company's revenue is concentrated in a single business segment, as no segmental breakdown is provided in the available data. Geographically, the company's exposure is not explicitly detailed, but the absence of segmental or geographic diversification suggests a potential concentration risk. This lack of diversification could make the company more vulnerable to regional or sector-specific downturns. Looking at the company's growth trajectory, there is no explicit guidance provided for the current or next fiscal year. However, the company's capital expenditure of INR 29.57 million (negative, indicating outflows) suggests a modest investment in future capacity or infrastructure. The absence of a clear growth strategy or significant capital allocation for expansion may limit the company's ability to scale operations or enter new markets. The risk assessment indicates a medium liquidity risk and a low dilution risk. The company's debt-to-equity ratio of 0.45 is relatively low, suggesting a conservative capital structure. However, the negative net cash position after debt is a red flag, as it implies that the company may need to raise additional capital or refinance debt in the near term. The dilution risk is currently low, as there is no indication of share buybacks, stock options, or convertible instruments that could increase the number of shares outstanding. Recent events and filings do not provide specific details on strategic initiatives or major corporate actions. The company's 10-K or equivalent filing does not appear to be publicly available in the provided data, so there is no direct insight into management's strategic direction or risk factors beyond what is disclosed in the financial snapshot.

30-day price · JAYO+1.59 (+14.7%)
Low$9.96High$15.18Close$12.44As of15 May, 00:00 UTC
Profile
CompanyJaysynth Orgochem Ltd
TickerJAYO.BO
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. (unavailable from LLM output)

Classification. (unavailable from LLM output)

Jaysynth Orgochem Ltd maintains a relatively strong liquidity position, with a current ratio of 4.91, indicating that the company has nearly five times more current assets than current liabilities. However, the company's net cash position is negative after subtracting total debt, which suggests that its cash and equivalents (INR 196.02 million) are insufficient to cover its long-term debt (INR 491.29 million). This highlights a potential liquidity risk, despite the high current ratio. In terms of profitability, the company's return on equity (ROE) of 11.15% and return on assets (ROA) of 6.27% are both below the typical thresholds for high-performing specialty chemical firms. These metrics suggest that the company is generating returns, but not at a level that would be considered exceptional within the industry. The operating margin, calculated as operating income (INR 155.71 million) divided by revenue (INR 2.11 billion), is approximately 7.37%, which is in line with the industry median for similar-sized firms. The company's revenue is concentrated in a single business segment, as no segmental breakdown is provided in the available data. Geographically, the company's exposure is not explicitly detailed, but the absence of segmental or geographic diversification suggests a potential concentration risk. This lack of diversification could make the company more vulnerable to regional or sector-specific downturns. Looking at the company's growth trajectory, there is no explicit guidance provided for the current or next fiscal year. However, the company's capital expenditure of INR 29.57 million (negative, indicating outflows) suggests a modest investment in future capacity or infrastructure. The absence of a clear growth strategy or significant capital allocation for expansion may limit the company's ability to scale operations or enter new markets. The risk assessment indicates a medium liquidity risk and a low dilution risk. The company's debt-to-equity ratio of 0.45 is relatively low, suggesting a conservative capital structure. However, the negative net cash position after debt is a red flag, as it implies that the company may need to raise additional capital or refinance debt in the near term. The dilution risk is currently low, as there is no indication of share buybacks, stock options, or convertible instruments that could increase the number of shares outstanding. Recent events and filings do not provide specific details on strategic initiatives or major corporate actions. The company's 10-K or equivalent filing does not appear to be publicly available in the provided data, so there is no direct insight into management's strategic direction or risk factors beyond what is disclosed in the financial snapshot.
Key takeaways
  • Jaysynth Orgochem Ltd has a strong current ratio but a negative net cash position after debt, indicating potential liquidity risk.
  • The company's ROE and ROA are below industry benchmarks, suggesting moderate profitability.
  • The company's revenue and operations are not segmented or geographically diversified, increasing concentration risk.
  • Capital expenditure is modest, and there is no clear growth strategy outlined in the available data.
  • The company's debt-to-equity ratio is low, but the negative net cash position raises concerns about refinancing needs.
  • --
  • **RATIONALES**:
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue$2.11B
Gross profit$639.5M
Operating income$155.7M
Net income$123.0M
R&D
SG&A
D&A
SBC
Operating cash flow$65.2M
CapEx-$29.6M
Free cash flow
Total assets$1.96B
Total liabilities$859.7M
Total equity$1.10B
Cash & equivalents$196.0M
Long-term debt$491.3M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$12.3M-$13.2M-$8.5M-$270.7k
FY-3$14.6M-$11.5M-$11.5M-$4.4M
FY-2$9.8M-$63.0M-$64.9M-$63.1M
FY-1$2.11B$151.2M$122.9M$118.3M
FY0$2.28B$199.8M$156.2M$131.8M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$58.2M-$185.5M$1.4M
FY-3$48.5M-$197.2M$3.3M
FY-2$47.8M-$262.2M$2.4M
FY-1$1.96B$1.10B$196.0M
FY0$2.06B$1.23B$177.9M
PeriodOCFCapExFCFSBC
FY-4-$4.2M-$270.7k
FY-3-$4.2M-$4.4M
FY-2-$93.6M-$63.1M
FY-1$65.2M-$29.6M$118.3M
FY0$65.8M-$29.8M$131.8M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$2.11B$155.7M$123.0M
FQ-6$503.7M$34.9M$28.6M
FQ-5$574.6M$55.4M$42.4M
FQ-4$603.6M$61.0M$54.6M
FQ-3$598.4M$46.7M$30.6M
FQ-2$590.1M$30.2M$17.2M
FQ-1$658.0M$56.9M$49.5M
FQ0$654.0M$32.1M$23.3M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$1.96B$1.10B$196.0M
FQ-6
FQ-5$2.03B$1.17B$170.0M
FQ-4
FQ-3$2.06B$1.23B$177.9M
FQ-2
FQ-1$2.15B$1.29B$82.3M
FQ0
PeriodOCFCapExFCFSBC
FQ-7$65.2M-$29.6M
FQ-6
FQ-5-$14.8M-$10.6M
FQ-4
FQ-3$65.8M-$29.8M
FQ-2
FQ-1-$116.1M-$38.4M
FQ0
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$1.10B
Net cash-$295.3M
Current ratio4.9
Debt/Equity0.5
ROA6.3%
ROE11.2%
Cash conversion53.0%
CapEx/Revenue-1.4%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
MetricJAYOActivity
Op margin7.4%5.5% medp25 -0.0% · p75 10.8%above median
Net margin5.8%4.1% medp25 0.1% · p75 8.8%above median
Gross margin30.3%20.5% medp25 12.4% · p75 29.7%top quartile
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-1.4%-6.2% medp25 -13.4% · p75 -2.6%top quartile
Debt / equity45.0%37.1% medp25 10.3% · p75 82.0%above median
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 00:29 UTC#ff5ba7de
Source: analysis-pipeline (hybrid)Generated: 2026-05-28 06:33 UTCJob: 01bd7ca3